-
1by Ming-Lun Yeh, Cheng-Yuan Peng, Chia-Yen Dai, Hsueh-Chou Lai, Chung-Feng Huang, Ming-Yen Hsieh, Jee-Fu Huang, Shinn-Cherng Chen, Zu-Yau Lin, Ming-Lung Yu, Wan-Long Chuang“...Studies are limited on pegylated interferon (Peg-IFN) therapy for chronic hepatitis B (CHB...”
Published 2015-01-01
Get full text
Article -
2by Jee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, Chia-Yen Dai, Meng-Hsuan Hsieh, Jeng-Fu Yang, Ching-I. Huang, Yi-Hung Lin, Po-Cheng Liang, Zu-Yau Lin, Shinn-Chern Chen, Ming-Lung Yu, Wan-Long ChuangGet full text
Published 2017-11-01
Article -
3by Ta-Ya Lin, Ming-Lun Yeh, Ching-I Huang, Yao-Li Chen, Chia-Yen Dai, Jee-Fu Huang, Zu-Yau Lin, Shinn-Cherng Chen, Chung-Feng Huang, Ming-Lung Yu, Wan-Long Chuang“.... Antiviral therapy is suggested after liver transplant to halt disease progression. Pegylated interferon plus...”
Published 2017-06-01
Get full text
Article -
4by Po-Cheng Liang, Pei-Chin Lin, Ching-I. Huang, Chung-Feng Huang, Ming-Lun Yeh, Yu-Sheng Zeng, Wan-Yi Hsu, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Shyh-Shin Chiou, Ming-Lung YuSubjects: “...Interferon...”
Published 2018-01-01
Get full text
Article -
5“...碩士 === 高雄醫學大學 === 臨床醫學研究所 === 102 === Background Pegylated interferon (peginterferon) and ribavirin...”
Get full text
Others -
6by Pei-Chien Tsai, Ta-Wei Liu, Meng-Hsuan Hsieh, Ming-Lun Yeh, Po-Cheng Liang, Yi-Hung Lin, Ching-I Huang, Chung-Feng Huang, Ming-Yen Hsieh, Nai-Jen Hou, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung YuSubjects: “...Pegylated interferon...”
Published 2017-01-01
Get full text
Article -
7“... inflammation, and the response to interferon with ribavirin combination therapy in patients with chronic...”
Get full text
Others -
8by Ming-Lun Yeh, Chao-Hung Hung, Jee-Fu Huang, Chun-Jen Liu, Chuan-Mo Lee, Chia-Yen Dai, Jing-Houng Wang, Zu-Yau Lin, Sheng-Nan Lu, Tsung-Hui Hu, Ming-Lung Yu, Jia-Horng Kao, Wan-Long Chuang, Pei-Jer Chen, Ding-Shinn Chen“...BACKGROUND: Interferon-α/ribavirin combination therapy might promote hepatitis B surface antigen...”
Published 2011-01-01
Get full text
Article -
9by Ta-Wei Liu, Pei-Chien Tsai, Ching-I Huang, Yi-Shan Tsai, Shu-Chi Wang, Yu-Min Ko, Ching-Chih Lin, Kuan-Yu Chen, Po-Cheng Liang, Yi-Hung Lin, Ming-Yen Hsieh, Nai-Jen Hou, Chung-Feng Huang, Ming-Lun Yeh, Zu-Yau Lin, Shinn-Cherng Chen, Chia-Yen Dai, Wan-Long Chuang, Jee-Fu Huang, Ming-Lung YuSubjects: “...pegylated interferon...”
Published 2018-01-01
Get full text
Article -
10
-
11by Ming-Yen Hsieh, Li-Po Lee, Nai-Jen Hou, Jeng-Fu Yang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Yuh Hsieh, Liang-Yen Wang, Wen-Yu Chang, Ming-Lung YuSubjects: “...interferon therapy...”
Published 2007-07-01
Get full text
Article -
12by Philip Vutien, Michelle Jin, Michael H Le, Pauline Nguyen, Sam Trinh, Jee-Fu Huang, Ming-Lung Yu, Wan-Long Chuang, Mindie H Nguyen“...Treatment rates with interferon-based therapies for chronic hepatitis C have been low. Our aim...”
Published 2017-01-01
Get full text
Article -
13“... and treatment of CHC. Interferon-α (IFN-α) is the effective anti-HCV agent which has become the standard agent...”
Get full text
Others -
14“... regimens. The long-term benefits of administering interferon-based therapy to elderly patients with HCV...”
Get full text
Article -
15by Shih-Jer Hsu, Ming-Lung Yu, Chien-Wei Su, Cheng-Yuan Peng, Rong-Nan Chien, Hsien-Hong Lin, Gin-Ho Lo, Wei-Wen Su, Hsing-Tao Kuo, Chao-Wei Hsu, Sien-Sing Yang, Sheng-Shun Yang, Kuan-Chiao Tseng, Albert Qin, Yi-Wen Huang, Wan-Long Chuang“...Background: Ropeginterferon alfa-2b is a novel mono-pegylated interferon that has only one major...”
Published 2021-03-01
Get full text
Article -
16by Ming-Lung Yu, Chao-Hung Hung, Yi-Hsiang Huang, Cheng-Yuan Peng, Chun-Yen Lin, Pin-Nan Cheng, Rong-Nan Chien, Shih-Jer Hsu, Chen-Hua Liu, Chung-Feng Huang, Chien-Wei Su, Jee-Fu Huang, Chun-Jen Liu, Jia-Horng Kao, Wan-Long Chuang, Pei-Jer Chen, Ding-Shinn Chen“... phase III study, a total of 70 interferon-naïve or interferon-experienced HCV-1b patients without...”
Published 2019-02-01
Get full text
Article -
17by Mei-Hsuan Lee, Chung-Feng Huang, Hsueh-Chou Lai, Chun-Yen Lin, Chia-Yen Dai, Chun-Jen Liu, Jing-Houng Wang, Jee-Fu Huang, Wen-Pang Su, Hung-Chih Yang, Kwong-Ming Kee, Ming-Lun Yeh, Po-Heng Chuang, Shih-Jer Hsu, Ching-I Huang, Jung-Ta Kao, Chieh-Chang Chen, Sheng-Hung Chen, Wen-Juei Jeng, Hwai-I Yang, Yong Yuan, Sheng-Nan Lu, I-Shyan Sheen, Chen-Hua Liu, Cheng-Yuan Peng, Jia-Horng Kao, Ming-Lung Yu, Wan-Long Chuang, Chien-Jen Chen“...). A total of 4639 patients who received pegylated interferon and ribavirin during 2004–2013 were...”
Published 2017-06-01
Get full text
Article -
18by Ming-Lung Yu, Yao-Li Chen, Chung-Feng Huang, Kuo-Hua Lin, Ming-Lun Yeh, Ching-I. Huang, Meng-Hsuan Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang“... (two treatment-naïve patients and one interferon-intolerant patient) were treated for 12 weeks. HCV RNA...”
Published 2018-06-01
Get full text
Article -
19by Chao-Wei Hsu, Wei-Wen Su, Chuan-Mo Lee, Cheng-Yuan Peng, Wan-Long Chuang, Jia-Horng Kao, Heng-Cheng Chu, Yi-Hsiang Huang, Rong-Nan Chien, Yun-Fan Liaw“...Background: Efficacy of sequential therapy with nucleos(t)ide analogues and interferons versus...”
Published 2018-07-01
Get full text
Article